Awakn Life Sciences Corp.: Awakn Successfully Completes Phase One of Its Drug Discovery Program

Two Chemical Series Identified to Facilitate Lead Optimisation Activities
Toronto, Ontario--(Newsfile Corp. - April 6, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn')

Related Keywords

Canada ,United States ,Toronto ,Ontario ,America ,Anne Donohoe ,David Nutt ,Paul Jarman Nora Popova ,Linkedin Facebook ,Valter Pinto Tim Regan ,Awakn Life Sciences ,Strategic Communications ,Newsfile Corp ,Nutt Equasy Enterprises ,Awakn Life Sciences Corp ,Two Chemical Series Identified ,Facilitate Lead Optimisation ,Life Sciences ,Chief Research Officer ,Equasy Enterprises ,United States Securities Act ,Awakn ,Life ,Ciences ,Orp ,Uccessfully ,Ompletes ,Hase ,Drug ,Discovery ,Program ,